Works matching AU Rohmer, V.

Results: 27

Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.252791

By:

Bodet-Milin, C.;
Faivre-Chauvet, A.;
Carlier, T.;
Ansquer, C.;
Rauscher, A.;
Frampas1-, E.;
Toulgoat, F.;
Masson, D.;
Bourgeois, M.;
Cerato, E.;
Rohmer, V.;
Couturier, O.;
Drui, D.;
Goldenberg, D. M.;
Sharkey, R. M.;
Barbet, J.;
Kraeber-Bodere, F.

Publication type:

Article

Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.252791

By:

Bodet-Milin, C.;
Faivre-Chauvet, A.;
Carlier, T.;
Ansquer, C.;
Rauscher, A.;
Frampas1-, E.;
Toulgoat, F.;
Masson, D.;
Bourgeois, M.;
Cerato, E.;
Rohmer, V.;
Couturier, O.;
Drui, D.;
Goldenberg, D. M.;
Sharkey, R. M.;
Barbet, J.;
Kraeber-Bodere, F.

Publication type:

Article

Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study. .

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.252791

By:

Bodet-Milin, C.;
Faivre-Chauvet, A.;
Carlier, T.;
Ansquer, C.;
Rauscher, A.;
Frampas, E.;
Toulgoat, F.;
Masson, D.;
Bourgeois, M.;
Cerato, E.;
Rohmer, V.;
Couturier, O.;
Drui, D.;
Goldenberg, D. M.;
Sharkey, R. M.;
Barbet, J.;
Kraeber-Bodere, F.

Publication type:

Article

Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post-hoc analysis of the iPET-MTC study.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.252791

By:

Bodet-Milin, C.;
Faivre-Chauvet, A.;
Carlier, T.;
Ansquer, C.;
Rauscher, A.;
Frampas, E.;
Toulgoat, F.;
Masson, D.;
Bourgeois, M.;
Cerato, E.;
Rohmer, V.;
Couturier, O.;
Drui, D.;
Goldenberg, D. M.;
Sharkey, R. M.;
Barbet, J.;
Kraeber-Bodere, F.

Publication type:

Article

Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.252791

By:

Bodet-Milin, C.;
Faivre-Chauvet, A.;
Carlier, T.;
Ansquer, C.;
Rauscher, A.;
Frampas, E.;
Toulgoat, F.;
Masson, D.;
Bourgeois, M.;
Cerato, E.;
Rohmer, V.;
Couturier, O.;
Drui, D.;
Goldenberg, D. M.;
Sharkey, R. M.;
Barbet, J.;
Kraeber-Bodere, F.

Publication type:

Article

Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 37, doi. 10.2967/jnumed.120.252791

By:

Bodet-Milin, C.;
Faivre-Chauvet, A.;
Carlier, T.;
Ansquer, C.;
Rauscher, A.;
Frampas, E.;
Toulgoat, F.;
Masson, D.;
Bourgeois, M.;
Cerato, E.;
Rohmer, V.;
Couturier, O.;
Drui, D.;
Goldenberg, D. M.;
Sharkey, R. M.;
Barbet, J.;
Kraeber-Bodere, F.

Publication type:

Article

Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post-hoc analysis of the iPET-MTC study.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.252791

By:

Bodet-Milin, C.;
Faivre-Chauvet, A.;
Carlier, T.;
Ansquer, C.;
Rauscher, A.;
Frampas, E.;
Toulgoat, F.;
Masson, D.;
Bourgeois, M.;
Cerato, E.;
Rohmer, V.;
Couturier, O.;
Drui, D.;
Goldenberg, D. M.;
Sharkey, R. M.;
Barbet, J.;
Kraeber-Bodere, F.

Publication type:

Article

Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post-hoc analysis of the iPET-MTC study.

Published in:

Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.252791

By:

Bodet-Milin, C.;
Faivre-Chauvet, A.;
Carlier, T.;
Ansquer, C.;
Rauscher, A.;
Frampas, E.;
Toulgoat, F.;
Masson, D.;
Bourgeois, M.;
Cerato, E.;
Rohmer, V.;
Couturier, O.;
Drui, D.;
Goldenberg, D. M.;
Sharkey, R. M.;
Barbet, J.;
Kraeber-Bodere, F.

Publication type:

Article

Efficacy of Everolimus in Patients with Metastatic Insulinomas and Refractory Hypoglycemia: For the French Group of Endocrine Tumors (GTE-Renaten).

Published in:

Neuroendocrinology, 2012, v. 96, p. 20

By:

Bernard, V.;
Lombard-Bohas, C.;
Goichot, B.;
Rohmer, V.;
Guimbaud, R.;
Niccoli, P.;
Chougnet, C.;
Ruszniewski, P.;
Baudin, E.

Publication type:

Article

Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.

Published in:

Clinical Endocrinology, 2004, v. 61, n. 3, p. 311, doi. 10.1111/j.1365-2265.2004.02048.x

By:

Reznik, V.;
Lefebvret, H.;
Rohmer, V.;
Charbonnel, B.;
Tabarini, A.;
Rodien, P.;
Lecomte, P.;
Bardet, S.;
Coffin, C.;
Mahoudeau, J.

Publication type:

Article

Clinical Characterization of Familial Isolated Pituitary Adenomas.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 9, p. 3316, doi. 10.1210/jc.2005-2671

By:

Daly, A. F.;
Jaffrain-Rea, M.-L.;
Ciccarelli, A.;
Valdes-Socin, H.;
Rohmer, V.;
Tamburrano, G.;
Borson-Chazot, C.;
Estour, B.;
Ciccarelli, E.;
Brue, T.;
Ferolla, P.;
Emy, P.;
Colao, A.;
Menis, E. De;
Lecomte, P.;
Penfornis, F.;
Delemer, B.;
Bertherat, J.;
Wémeau, J. L.;
Herder, W. De

Publication type:

Article

Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.

Published in:

2006

By:

Moran, C;
Azziz, R;
Weintrob, N;
Witchel, S F;
Rohmer, V;
Dewailly, D;
Marcondes, J A M;
Pugeat, M;
Speiser, P W;
Pignatelli, D;
Mendonca, B B;
Bachega, T A S;
Escobar-Morreale, H F;
Carmina, E;
Fruzzetti, F;
Kelestimur, F

Publication type:

journal article

Octreotide (Long-Acting Release Formulation) Treatment in Patients with Graves’ Orbitopathy: Clinical Results of a Four-Month, Randomized, Placebo-Controlled, Double-Blind Study.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 2, p. 841, doi. 10.1210/jc.2004-1334

By:

Wémeau, J. L.;
Caron, P.;
Beckers, A.;
Rohmer, V.;
Orgiazzi, J.;
Borson-Chazot, F.;
Nocaudie, M.;
Perimenis, P.;
Bisot-Locard, S.;
Bourdeix, I.;
Dejager, S.

Publication type:

Article

Analysis of Tg Transcripts by Real-Time RT-PCR in the Blood of Thyroid Cancer Patients.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 2, p. 635, doi. 10.1210/jcem.87.2.8203

By:

SAVAGNER, F.;
RODIEN, P.;
REYNIER, P.;
ROHMER, V.;
BIGORGNE, J.-C.;
MALTHIERY, Y.

Publication type:

Article

Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases.

Published in:

2012

By:

Garby L;
Caron P;
Claustrat F;
Chanson P;
Tabarin A;
Rohmer V;
Arnault G;
Bonnet F;
Chabre O;
Christin-Maitre S;
du-Boullay H;
Murat A;
Nakib I;
Sadoul JL;
Sassolas G;
Claustrat B;
Raverot G;
Borson-Chazot F;
GTE Group

Publication type:

Journal Article

Prognostic Factors of Disease-Free Survival after Thyroidectomy in 170 Young Patients with a RET Germline Mutation: A Multicenter Study of the Groupe Français d’Etude des Tumeurs Endocrines.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 3, p. E509, doi. 10.1210/jc.2010-1234

By:

Rohmer, V.;
Vidal-Trecan, G.;
Bourdelot, A.;
Niccoli, P.;
Murat, A.;
Wemeau, J. L.;
Borson-Chazot, F.;
Schvartz, C.;
Tabarinc, A.;
Chabre, O.;
Chabrier, G.;
Caron, P.;
Rodien, P.;
Schlumberger, M.;
Baudin, E.

Publication type:

Article

A Pulmonary Adrenocorticotropin-Secreting Carcinoid Tumor Localized by 6-Fluoro-[<sup>18</sup>F]LDihydroxyphenylalanine Positron Emission/Computed Tomography Imaging in a Patient with Cushing’s Syndrome.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2007, v. 92, n. 12, p. 4512, doi. 10.1210/jc.2007-1337

By:

Dubois, S.;
Morel, O.;
Rodien, P.;
Illouz, F.;
Girault, S.;
Cahouet, A.;
Lacoeuille, F.;
Brousseau, M.;
Picquet, J.;
Rohmer, V.

Publication type:

Article

Les tumeurs neuroendocrines.

Published in:

Oncologie (Tech Science Press), 2020, v. 21, n. 1, p. 73, doi. 10.3166/onco-2019-0045

By:

Rohmer, V.

Publication type:

Article

Aspects génétiques des tumeurs neuroendocrines.

Published in:

Oncologie (Tech Science Press), 2013, v. 15, n. 10/11, p. 515, doi. 10.1007/s10269-013-2330-6

By:

Rohmer, V.

Publication type:

Article

Cabergoline for Cushing’s disease: a large retrospective multicenter study.

Published in:

European Journal of Endocrinology, 2017, v. 176, n. 3, p. 305, doi. 10.1530/EJE-16-0662

By:

Ferriere, A.;
Cortet, C.;
Chanson, P.;
Delemer, B.;
Caron, P.;
Chabre, O.;
Reznik, Y.;
Bertherat, J.;
Rohmer, V.;
Briet, C.;
Raingeard, I.;
Castinetti, F.;
Beckers, A.;
Vroonen, L.;
Maiter, D.;
Cephise-Velayoudom, F. L.;
Nunes, M. L.;
Haissaguerre, M.;
Tabarin, A.

Publication type:

Article

Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'étude des Tumeurs Endocrines database.

Published in:

European Journal of Endocrinology, 2012, v. 166, n. 2, p. 269, doi. 10.1530/EJE-11-0679

By:

Gatta-Cherifi, B.;
Chabre, O.;
Murat, A.;
Niccoli, P.;
Cardot-Bauters, C.;
Rohmer, V.;
Young, J.;
Delemer, B.;
Du Boullay, H.;
Verger, M. F.;
Kuhn, J. M.;
Sadoul, J. L.;
Ruszniewski, P. h.;
Beckers, A.;
Monsaingeon, M.;
Baudin, E.;
Goudet, P.;
Tabarin, A.

Publication type:

Article

The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients.

Published in:

European Journal of Endocrinology, 2003, v. 148, n. 4, p. 0433, doi. 10.1530/eje.0.1480433

By:

H Valdes Socin;
P Chanson;
B Delemer;
A Tabarin;
V Rohmer;
J Mockel;
A Stevenaert;
A Beckers

Publication type:

Article

Non-Hodgkin's lymphoma presenting with primary adrenal insufficiency. A disease with an underestimated frequency?

Published in:

1992

By:

Gamelin, Erick;
Beldent, Véronique;
Rousselet, Marie-Christine;
Rieux, Denise;
Rohmer, Vincent;
Ifrah, Norbert;
Boasson, Marc;
Bigorgne, Jean-Claude;
Gamelin, E;
Beldent, V;
Rousselet, M C;
Rieux, D;
Rohmer, V;
Ifrah, N;
Boasson, M;
Bigorgne, J C

Publication type:

journal article

Oligoasthenospermia associated with multiple mitochondrial DNA rearrangements.

Published in:

Molecular Human Reproduction, 1997, v. 3, n. 9, p. 811, doi. 10.1093/molehr/3.9.811

By:

Lestienne, P;
Reynier, P;
Penisson-Besnier, I;
MalthiÃ¨ry, Y;
Rohmer, V

Publication type:

Article

No Evidence of Thyrotropin Receptor and G<sub>Sα</sub> Gene Mutation in High Iodine Uptake Thyroid Carcinoma.

Published in:

Thyroid, 2000, v. 10, n. 9, p. 761, doi. 10.1089/thy.2000.10.761

By:

Bourasseau, I.;
Savagner, F.;
Rodien, P.;
Duquenne, M.;
Reynier, P.;
Guyetant, S.;
Bigorgne, J.C.;
Malthièry, Y.;
Rohmer, V.

Publication type:

Article

Telematic transmission of computerized blood glucose profiles for IDDM patients.

Published in:

1991

By:

Billiard, Alain;
Rohmer, Vincent;
Roques, Marie-Agnès;
Joseph, Marie-Geneviève;
Suraniti, Sylveslro;
Giraud, Philippe;
Limal, Jean-Marie;
Fressinaud, Philippe;
Marre, Michel;
Billiard, A;
Rohmer, V;
Roques, M A;
Joseph, M G;
Suraniti, S;
Giraud, P;
Limal, J M;
Fressinaud, P;
Marre, M

Publication type:

journal article

GH deficiency in adults: an epidemiological approach.

Published in:

European Journal of Endocrinology, 1999, v. 141, n. 6, p. 595, doi. 10.1530/eje.0.1410595

By:

Sassolas, G.;
Chazot, F. Borson;
Jaquet, P.;
Bachelot, I.;
Chanson, P.;
Rudelli, C. Cortet;
Tauber, J. P.;
Allannic, H.;
Bringer, J.;
Roudaut, N.;
Rohmer, V.;
Roger, P.;
Latapie, J. L.;
Reville, P.;
Leutenegger, M.

Publication type:

Article